Found: 20
Select item for more details and to access through your institution.
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 193, doi. 10.1111/bjh.15440
- By:
- Publication type:
- Article
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
- By:
- Publication type:
- Article
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
- Published in:
- Current Oncology, 2023, v. 30, n. 1, p. 274, doi. 10.3390/curroncol30010022
- By:
- Publication type:
- Article
Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 3, p. 1080, doi. 10.1007/s00415-023-12157-4
- By:
- Publication type:
- Article
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1033413
- By:
- Publication type:
- Article
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 189, doi. 10.1111/bjh.19517
- By:
- Publication type:
- Article
Focal adhesion kinase activation by calcium‐dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 224, doi. 10.1111/bjh.18996
- By:
- Publication type:
- Article
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 193, doi. 10.1111/bjh.15440
- By:
- Publication type:
- Article
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185626
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1095, doi. 10.3390/cancers16061095
- By:
- Publication type:
- Article
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1562, doi. 10.3390/cancers14061562
- By:
- Publication type:
- Article
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5453, doi. 10.3390/cancers13215453
- By:
- Publication type:
- Article
Anaemia during venetoclax ramp‐up phase: Do not forget unusual causes.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 823, doi. 10.1002/hon.2810
- By:
- Publication type:
- Article
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases.
- Published in:
- 2018
- By:
- Publication type:
- case study
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 9679, doi. 10.2147/OTT.S268899
- By:
- Publication type:
- Article
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1370405
- By:
- Publication type:
- Article
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article